1466663

N-亚硝基二异丙基胺(NDIPA)

United States Pharmacopeia (USP) Reference Standard

• 别名: N-Isopropyl-N-nitrosoisopropylamine, DIPNA, NDIP
• 经验公式（希尔记法）: C₆H₁₄N₂O
• CAS号: 601-77-4
• 分子量: 130.19
• MDL编号: MFCD00015392
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 包装: pkg of 1 mg (in 1 mL methanol)
• 制造商/商品名称: USP
• 应用: pharmaceutical (small molecules)
• 包装形式: single component solution
• 储存温度: −20°C
• SMILES字符串: N(N=O)(C(C)C)C(C)C
• InChI: 1S/C6H14N2O/c1-5(2)8(7-9)6(3)4/h5-6H,1-4H3
• InChI key: AUIKJTGFPFLMFP-UHFFFAOYSA-N

说明

一般描述

This product is provided as delivered and specified by the USP Pharmacopoeia. For further information and support, including certificate/ product information sheets, please go to the website of the issuing Pharmacopoeia.

应用

N-Nitrosodiisopropylamine (NDIPA) USP reference standard is intended for use only as specifically prescribed in the United States Pharmacopoeia.

It is also used to prepare standard, standard stock, nitrosamine RS stock, Nitrosamine standards stock solution mixture, and sensitivity stock solutions to determine NDIPA impurity in drug substances and drug products (valsartan, irbesartan, and losartan potassium etc) by chromatography according to general chapter 〈1469〉 of United States Pharmacopeia.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

其他说明

Sales restrictions may apply.

安全信息

• 象形图: GHS02,GHS06,GHS08
• 警示用语：: Danger
• 危险声明: H225,H301 + H311 + H331,H350,H370
• 预防措施声明: P202 - P210 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危险分类: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - Flam. Liq. 2 - STOT SE 1
• 靶器官: Eyes,Central nervous system
• 储存分类代码: 3 - Flammable liquids
• WGK: WGK 3
• 闪点(°F): 49.5 °F
• 闪点(°C): 9.7 °C